Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic ControlĀ® Platform
Go back to Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic ControlĀ® Platform| (NASDAQ: FHTX) | Delayed: 4.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.18 | 52 Week High | $ | |||
| Open | $4.18 | 52 Week Low | $ | |||
| Day High | $4.18 | P/E | N/A | |||
| Day Low | $4.18 | EPS | $ | |||
| Volume | 10 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1102.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1102.08 | 52 Week High | $88.16 | |||
| Open | $1102.08 | 52 Week Low | $67.88 | |||
| Day High | $1102.08 | P/E | 255.11 | |||
| Day Low | $1102.08 | EPS | $4.32 | |||
| Volume | 14,243 | |||||

